Details

Last Funding Type

Series A

Last Funding Money Raised

$30M

Industries

Biotechnology,Health Care,Life Science,Pharmaceutical

Founded date

Nov 1, 2020

Number Of Employee

11 - 50

Operating Status

Active

Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.

It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.